THE PERSISTENCE OF ANTI-SPIKE ANTIBODIES FOLLOWING TWO SARS-COV-2 VACCINES IN PATIENTS WITH INFLAMMATORY BOWEL- AND JOINT DISEASES ON IMMUNOSUPPRESSIVE THERAPY COMPARED TO HEALTHY CONTROLS – A PROSPECTIVE COHORT STUDY

Kristin Kaasen Jørgensen  ¹     Ingrid E. Christensen  ²     Ingrid Jyssum  ²     Anne T. Tveter  ²     Joseph Sexton  ²     Trung T. Tran  ³     Siri Mjaaland  ⁴     Grete Kro  ⁴     Tore K Kvien  ⁴     David J. Warren  ⁴     Jørgen Jahnsen  ⁵     Ludvig A. Munthe  ⁵     Espen A Haavardsholm  ⁵     John T. Vaage  ⁵     Gunnveig Grødeland  ⁵     Fridtjof Lund-Johansen  ⁵     Silje W. Syversen  ⁵     Guro Lovik Goll  ⁵     Sella A. Provan  ^5    
1 Akershus University Hospital, Lørenskog, Norway
² Diakonhjemmet Hospital, Oslo, Norway
³ Oslo University Hospital, Oslo, Norway
⁴ Norwegian Institute of Public Health, Oslo, Norway
⁵ University of Oslo, Oslo, Norway

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)